The incidence of infectious complications during the childhood ALL induction phase with BFM/ALL/NHL/86 protocol.
Tontoli
N
N
I Pediatric Division, SS. Annunziata Hospital, Naples, Italy.
Pelliccia
A
A
Guerriero
A
A
Correra
A
A
Montaldo
A
A
Tancredi
F
F
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D006801:Humans; D007223:Infant; D017053:Infection Control; D007239:Infections / Q000150:complications*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy
D000890:Anti-Infective Agents